Janssen has lost yet another Risperdal trial.  On July 1, 2016, a jury awarded the plaintiff, a young man who asserted he grew breasts after taking the drug, a $70 million verdict. Janssen still faces 1,700 more cases pending against the company for their failure to provide proper warnings to